Ally Bridge Group »

Traws Pharma shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $663k 786k 0.84

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding Traws Pharma

OrbiMed Advisors
Ally Bridge Group
Adage Capital Partners GP
ADAR1 Capital Management
Lynx1 Capital Management
Ikarian Capital
Sphera Funds Management
Vanguard Capital Management
Jane Street
Alyeska Investment Group
Boothbay Fund Management
Geode Capital Management
Hrt Financial
Kynam Capital Management
Dauntless Investment Group

View all funds holding Traws Pharma